Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
February 2013
Features
Hospitals Prepare for Medicare Cuts
The Need to Reduce the Federal Deficit Puts Seniors and Providers on Notice
In view of changing Medicare payment policies, hospitals reassess pharmacy procedures.
Stephen Barlas
The MAPK (ERK) Pathway
Investigational Combinations for the Treatment of BRAF-Mutated Metastatic Melanoma
The arrival of ipilimumab and vemurafenib has provided oncologists with new choices in a field in which options were slim and the prognosis was grim. Combination therapy may lead to an improved survival benefit.
Jack McCain
Cardiometabolic Consequences of Therapy for Chronic Schizophrenia Using Second-Generation Antipsychotic Agents in a Medicaid Population
Clinical and Economic Evaluation
A health economic model was constructed to predict the 5-year incidence of coronary heart disease and diabetes and associated costs after treatment in patients using second-generation antipsychotic agents.
Alex Ward, PhD, MRPharmS; Peter Quon, MPH; Safiya Abouzaid, PharmD; Noah Haber, MA; Saeed Ahmed, MD; and Edward Kim, MD, MBA
Meeting Highlights
American Society of Hematology
Drug therapies for multiple myeloma, mantle-cell lymphoma, and myelodysplastic syndromes
Walter Alexander
Meeting Highlights
2012 American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition
Generic biologics (e.g., biosimilars) and medication safety related to Joint
Commission hospital accreditation standards
Michele B. Kaufman, PharmD, RPh
Departments
Medication Errors
Scanning Too Many Orders at Once
The Result: Drug Orders Are Omitted
Drug orders can be accidentally omitted or misread if a scanner pulls too many pages through at once.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Hospitals Worry About New FDA Proposal for Medical Devices
Technical Complexities of Labels Could Compromise Utility
A proposed FDA rule on unique device identifcation could complicate billing and bar-coding procedures for hospitals.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Cabozantinib (Cometriq) for metastatic medullary thyroid cancer; ponatinib (Iclusig) for two forms of leukemia; and raxibacumab for inhalational anthrax
Marvin M. Goldenberg, PhD, RPh, MS
Drug Forecast
Bapineuzumab, an Investigational Agent For Alzheimer’s Disease
Farah Khorassani, PharmD, BCPS; and Olga Hilas, PharmD, MPH, BCPS, CGP
